Initial human clinical experience with diode laser interstitial treatment of benign prostatic hyperplasia

Author： Muschter R. De La Rosette J.J.M.C.H. Whitfield H. Pellerin J.-P. Madersbacher S. Gillatt D.

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.48, Iss.2, 1996-08, pp. : 223-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Laser treatment of benign prostatic hyperplasia

By Kuntz Rainer

World Journal of Urology, Vol. 25, Iss. 3, 2007-06 ,pp. : 241-247

Springer Publishing Company

Access to resources Recommend Favorite

Intraprostatic botulinum toxin type A injection for the treatment of benign prostatic hyperplasia: Initial experience with Dysport™™

By Nikoobakht Mohammadreza Daneshpajooh Azar Ahmadi Hamed Namdari Farshad Rezaeidanesh Maedeh Amini Shahab Pourmand Gholamreza

Scandinavian Journal of Urology and Nephrology, Vol. 44, Iss. 3, 2010-04 ,pp. : 151-157

Informa Healthcare

Access to resources Recommend Favorite

Discontinuation of alpha-blockade after initial treatment with finasteride and doxazosin in men with lower urinary tract symptoms and clinical evidence of benign prostatic hyperplasia

By Baldwin K.C. Ginsberg P.C. Roehrborn C.G. Harkaway R.C.

Urology, Vol. 58, Iss. 2, 2001-08 ,pp. : 203-208

Elsevier

Access to resources Recommend Favorite

Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostatic hyperplasia

By Boyle P. Robertson C. Lowe F. Roehrborn C.

Urology, Vol. 55, Iss. 4, 2000-04 ,pp. : 533-539

Elsevier

Access to resources Recommend Favorite

Recruitment for a clinical trial of drug treatment for benign prostatic hyperplasia

By Kusek J.W. Ahrens A. Burrows P.K. Clarke H.S. Foster H.E. Hanson K. Jacobs S.C. Kirkemo A. O'Berry K. Pavlik V.N. for the MTOPS Research Group

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 63-67

Elsevier

Access to resources Recommend Favorite